Clinical trial
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing…
NCT00438659 · North Central Cancer Treatment Group, Other · Completed
Key facts
| NCT number | NCT00438659 |
|---|---|
| Title | Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ |
| Official title | Phase III Randomized Double-Blind Study of Mometasone Furoate Versus Placebo in the Prevention of Radiation Dermatitis in Breast Cancer Patients Receiving Radiation Therapy |
| Lead sponsor | North Central Cancer Treatment Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy |
| Intervention type | Drug, Other |
| Interventions | mometasone furoate, placebo |
| Enrollment | 176 |
| Start date | Aug 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Jun 1, 2014 |
| First posted | Feb 22, 2007 |
| Last update posted | Aug 1, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: